Vaccine Technologies and Global Markets

July 06, 2011

Wellesley, Mass. – In a recent release, VACCINE TECHNOLOGIES AND GLOBAL MARKETS (PHM014D) from BCC Research (www.bccresearch.com), the global market for vaccines was worth $28.1 billion in 2010. That value is projected to be $64.2 billion in 2015, after increasing at a five-year compound annual growth rate (CAGR) of 17.9%.

The global market for vaccines can be broken down into two segments – human and animal.

The segment made up of human vaccines was valued at $23.9 billion in 2010, and in 2015 should be worth nearly $58.6 billion, yielding a CAGR of 19.6%.

The segment made up of animal vaccines, worth $4.2 billion in 2010, should rise to nearly $5.6 billion in 2015 at a CAGR of 5.7%.

A vaccine is a pharmaceutical preparation of biological ingredients that helps provide immunity to a particular disease. Vaccines stimulate the immune system to produce antibodies that can either prevent the disease or treat an existing disease.

Over the past few years, the global vaccines market has experienced some significant mergers and acquisitions that have left the industry with five major pharmaceutical companies – Pfizer, Sanofi-Aventis, GlaxoSmithKline, Merck & Co., and Novartis. These companies and the vaccines market are expected to show revenue increases, due to a growing market.

Several factors are currently driving market growth, most significantly an overall increase in global government involvement and regulation, development of safer and more effective vaccines, and a more enabled and readily available vaccine market for the general public. Additionally, nongovernment agencies such as the World Health Organization (WHO) and the United Nations Children’s Fund (UNICEF) have provided unprecedented support to the global vaccines industry. As long as public awareness continues to increase and new funding is invested in the research of finding new technologies, the overall vaccines industry will continue to demonstrate growth.

The report is presented from the point of view of manufacturers and users, and will be most helpful to clinicians, physicians, the pharmaceutical and biopharmaceutical industries, hospitals, and research institutes.

To Contact us, click here  

Vaccine Technologies and Global Markets( PHM014D )
Publish Date: Jan 2011    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.